Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
NCT ID: NCT00747201
Last Updated: 2014-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
384 participants
INTERVENTIONAL
2009-09-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing Health Plan-Level Care Management for Solo & Small Practices
NCT02041962
Disseminating Evidence-based Mood Disorder Chronic Care Models
NCT01615458
Improving Care for Patients With Bipolar Disorder
NCT00222755
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761
Modeling Mood Course to Detect Markers of Effective Adaptive Interventions
NCT03358238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Often, new results from research can take years or decades to be translated into practice in community mental health care. Even then, new methods can be less effective in practice because there is inadequate understanding of or technical support for these methods. This occurs because research is not presented in enough detail or with enough flexibility to be adapted for community settings.
The Centers for Disease Control and Prevention's (CDC's) Replicating Effective Programs (REP) project is a systematic method of replicating effective behavioral interventions for reducing HIV risk. The REP has three components:
* Packaging, or adapting, a behavioral treatment so its scientific protocols are in nontechnical, user-friendly language
* Providing formal training for health care professionals in implementing the package
* Supporting the use of the package through technical assistance available to individual treatment sites
The REP framework has been effective in extending the availability of HIV behavioral interventions and ensuring proper implementation, but it has never been used for non-HIV-related interventions, nor has it been proven that wider availability of these new interventions improves patient health and quality of life. This study will examine both of these untested areas of the REP framework by packaging a new intervention for bipolar disorder, called the Bipolar Care Model (BCM). Research shows the BCM to be effective in real-world settings and across different ethnic groups. This study will determine if a packaged version of the BCM will be effective across multiple, community-based, mental health settings. Success with the packaged version of the BCM will not only make this particular treatment more available to mental health care providers, but it will create a model for transitioning all research on new behavioral interventions for mental health into effective practice.
This study will last 2 years from its first implementation to the final collection of patient data at the participating mental health care sites. The care sites that will participate in this study will be randomly assigned to receive either the BCM package, training, and technical assistance or the BCM package alone. Adherence to the BCM model and patient outcomes at each care site will be measured at baseline and after 6, 12, and 24 months. Also at these intervals, patients at each care site will be contacted for a 30-minute survey on their treatment. Care sites will be assessed on the following: adherence to the BCM model, as assessed through site records; patient clinical outcomes, as assessed through questionnaires on bipolar symptoms, functioning, and quality of life; and costs, as assessed through records of training hours, technical assistance hours, and hours spent by REP implementers. The total cost of developing the intervention according to the REP framework will also be measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2 Packaged intervention only
Patients will be seen by providers who receive the intervention package only.
Bipolar Care Model Package Only
Health care providers will receive only the adapted manuals.
1 Packaged intervention, training, and technical assistance
Patients will be seen by providers who receive the packaged intervention, along with provider training and ongoing technical assistance.
Replicating Effective Programs Framework for the Bipolar Care Model
Health care providers will receive adapted manuals, training, and technical assistance in the bipolar care model.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Replicating Effective Programs Framework for the Bipolar Care Model
Health care providers will receive adapted manuals, training, and technical assistance in the bipolar care model.
Bipolar Care Model Package Only
Health care providers will receive only the adapted manuals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active diagnosis or treatment plan for Bipolar I, Bipolar II, or Bipolar not otherwise specified (NOS)
Exclusion Criteria
* Living in a nursing home or other institution
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy M. Kilbourne
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy M. Kilbourne, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado-Denver
Denver, Colorado, United States
Washtenaw Community Health Organization
Ann Arbor, Michigan, United States
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.